MENU
GYRE
AS OF
Nov 19, 04:59 PM (EDT)
Price
$7.58
Change
-$0.09 (-1.17%)
Capitalization
730.21M
132 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gyre Therapeutics (GYRE) Earnings Date & Reports

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis... Show more

A.I. Advisor
published Earnings

GYRE is expected to report earnings to rise 55.67% to 4 cents per share on March 31

Gyre Therapeutics GYRE Stock Earnings Reports
Q4'25
Est.
$0.05
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.02
Q2'23
Missed
by $0.98
Q1'23
Beat
by $0.22
The last earnings report on November 07 showed earnings per share of 2 cents, missing the estimate of 5 cents. With 41.65K shares outstanding, the current market capitalization sits at 730.21M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GYRE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GYRE showed earnings on November 07, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GYRE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com